G
Günther G. Steger
Researcher at Medical University of Vienna
Publications - 243
Citations - 11875
Günther G. Steger is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 41, co-authored 238 publications receiving 10859 citations. Previous affiliations of Günther G. Steger include University of Vienna.
Papers
More filters
Journal ArticleDOI
62-Month follow-up of ABCSG-12: Adjuvant endocrine therapy, alone or in combination with zoledronic acid, in premenopausal patients with endocrine-responsive early breast cancer
Michael Gnant,Brigitte Mlineritsch,Herbert Stoeger,G. Luschin-Ebengreuth,S. Poestlberger,Günther G. Steger,Raimund Jakesz,Christian F. Singer,H. Eidtmann,Richard Greil +9 more
TL;DR: A phase II, randomized, open-label, pilot study to evaluate the safety and the effects on bone resorption of saracatinib (AZD0530) in patients with prostate cancer or breast cancer with metastatic bone disease.
Journal Article
[Interferon alpha 2C in the treatment of 2 patients with AIDS-associated Kaposi sarcoma].
TL;DR: Two patients with AIDS and histologically confirmed Kaposi's sarcoma were treated with 3 X 10(6) U/m2 interferonalpha 2C (rIFN alpha 2C) subcutaneously three times a week and remissions of the tumour lesions were achieved and in one case pretherapeutic moderate thrombocytopenia improved.
Journal ArticleDOI
Opinions on the ASCO 2011 Annual Meeting.
TL;DR: Distant metastasis survival curves separate early, in fact, they seem to separate in parallel to the LRR curves, which is against the previous paradigm that at least 10% decrease of LRR needs to be achieved to have a significant shift in OS.
Journal ArticleDOI
5058 Bevacizumab (Bev) combined with either capecitabine (X) or weekly paclitaxel (Pac) as first-line therapy for HER2-negative locally recurrent or metastatic breast cancer (LR/MBC): the CECOG phase III TURANDOT trial
István Láng,Moshe Inbar,Günther G. Steger,Richard Greil,Z. Zvirbule,Semir Beslija,Zsuzsanna Kahán,V. Taskova,B. Kaufmann,Christoph C. Zielinski +9 more
Journal ArticleDOI
Metastatic or locally advanced breast cancer patients: towards an expert consensus on nab-paclitaxel treatment in HER2-negative tumours-the MACBETH project.
Marina Elena Cazzaniga,Eva Ciruelos,Alessandra Fabi,José A. García-Sáenz,Henrik Lindman,Dimitrios Mavroudis,C. Schem,Günther G. Steger,Eleni Timotheadou,Khalil Zaman,Valter Torri +10 more
TL;DR: Consensus was reached in 30.8% of the Nab-P statements, mainly those regarding safety issues, whereas ones regarding efficacy and schedule still remain controversial areas, requiring further data originated by the literature.